MedPath

Impact of Fascia Iliaca Block in Hip Fracture Patients

Not Applicable
Completed
Conditions
Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures)
Registration Number
NCT03525977
Lead Sponsor
Texas Tech University Health Sciences Center, El Paso
Brief Summary

The study is a prospective randomized examining the impact of fascia iliaca block on perioperative pain control and post operative ambulation in patients with hip fractures.

Detailed Description

Regional anesthesia is an important element of multimodal pain control regimen for surgical patients. Recently, regional anesthesia using a fascia iliaca block (FIB) to help treat pain in patients who present with hip fractures has been gaining popularity and has been incorporated as part of a multi-modal pain control protocol in many centers. It is commonly offered in addition to oral and intravenous medications to help patients deal with pain in the perioperative period. The block is done by an anesthesiologist under anesthesia using ultrasound guidance. We propose a prospective, randomized study evaluating the efficacy of the FIB as an adjunct in the pre-operative or postoperative period for pain control as measured by visual analog scale (VAS) scores and morphine equivalent dosing (MED), as well as its efficacy in promoting patient participation in physical therapy postoperatively in patients who present with hip fractures. We hypothesize that those patients who receive FIBs will report lower VAS scores as well as decreased narcotic requirement at all time points; and have improved participation in therapy when measured by ambulation distance.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
97
Inclusion Criteria
  • Patients with femoral neck and intertrochanteric hip fractures
  • At least 18 years of age
  • Require operative management
Exclusion Criteria
  • Poly-trauma patients
  • Pathologic fractures
  • Patient who required revision procedures
  • Patients with chronic opioid use
  • Patients with a clinical status that precludes verbal pain assessment such as dementia, head injuries, and unwillingness to participate.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Pain levelThree days after surgery

Visual analog scale scores and morphine equivalent dosing

Pain medication requirementThree days after surgery

Morphine equivalent dosing

Secondary Outcome Measures
NameTimeMethod
Ambulation distanceTwo days after surgery

Ambulation distance with physical therapy post op

Trial Locations

Locations (1)

University Medical Center

🇺🇸

El Paso, Texas, United States

University Medical Center
🇺🇸El Paso, Texas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.